| Typicality: | 0.347 |
| Saliency: | 0.228 |
| since 1995 | 3 | temporal |
| for rotavirus | 2 | purpose |
| vaccine → be approved in → the united states | 12 |
| vaccine → be approved in → the us | 4 |
| negative | neutral | positive |
| 0.081 | 0.529 | 0.389 |
| Raw frequency | 16 |
| Normalized frequency | 0.228 |
| Modifier score | 0.500 |
| Perplexity | 23.129 |